13F-HR filed by Krensavage Asset Management, LLC
Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 20 holding rows worth $255,697,000.
- Accession
- 0001609251-26-000004
- Filer
- CIK 1609251
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 20 entries on the cover page, a total value of $255,697,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $255,697,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 84,282 | $49,978,000 | thousands, detected and multiplied | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 2,866,138 | $36,199,000 | thousands, detected and multiplied | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 167,816 | $31,726,000 | thousands, detected and multiplied | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 524,786 | $29,645,000 | thousands, detected and multiplied | |
| EXELIXIS INC COM | 30161Q104 | Stock | 415,693 | $17,829,000 | thousands, detected and multiplied | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 323,946 | $15,608,000 | thousands, detected and multiplied | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 280,681 | $14,508,000 | thousands, detected and multiplied | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 339,532 | $10,349,000 | thousands, detected and multiplied | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 390,879 | $8,189,000 | thousands, detected and multiplied | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 1,180,388 | $8,156,000 | thousands, detected and multiplied | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 735,340 | $6,500,000 | thousands, detected and multiplied | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 96,729 | $5,338,000 | thousands, detected and multiplied | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 59,523 | $5,290,000 | thousands, detected and multiplied | |
| ALKERMES PLC | G01767105 | SHS | 107,822 | $3,813,000 | thousands, detected and multiplied | |
| BIOGEN INC COM | 09062X103 | Stock | 20,000 | $3,667,000 | thousands, detected and multiplied | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 4,000 | $3,091,000 | thousands, detected and multiplied | |
| ARDELYX INC | 039697107 | COM | 500,000 | $2,995,000 | thousands, detected and multiplied | |
| INMODE LTD SHS | M5425M103 | Stock | 120,942 | $1,654,000 | thousands, detected and multiplied | |
| EVOLUS INC | 30052C107 | COM | 157,985 | $649,000 | thousands, detected and multiplied | |
| Abbott Laboratories | 002824100 | COM | 5,000 | $513,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001609251-26-000004 | this filing | 2026-05-15 | acceptance time not in the bulk data set |